Vivaldi Biosciences
ID: 5291634Vivaldi Biosciences is a biotechnology company developing live attenuated influenza vaccines founded in 2010 by Adolfo García-Sastre, Peter Palese and Elliott Kieff.
1
Funding Rounds
$2.0m
Money raised
Recent Funding Rounds
Overview
Vivaldi Biosciences is a biotechnology company developing live attenuated influenza vaccines founded in 2010 by Adolfo García-Sastre, Peter Palese and Elliott Kieff.
- Website:
- Business model: B2B B2C
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad**** Ga************ | - | - | - |
| Pe*** Pa**** | - | - | - |
| El***** Ki*** | - | - | - |
Funding series
Funding Series Analysis
The company Vivaldi Biosciences has raised a total of $2m in funding over 1 rounds.
Key Insights:
- Vivaldi Biosciences Series A round: $2m
Industries
Vivaldi Biosciences is active in the following industries: